Top

Langenbeck's Archives of Surgery

Published in:

01-12-2015 | REVIEW ARTICLE

Surgical management of secondary hyperparathyroidism in chronic kidney disease—a consensus report of the European Society of Endocrine Surgeons

Authors: Kerstin Lorenz, Detlef K. Bartsch, Juan J. Sancho, Sebastien Guigard, Frederic Triponez

Published in: Langenbeck's Archives of Surgery | Issue 8/2015

Abstract

Background

Despite advances in the medical management of secondary hyperparathyroidism due to chronic renal failure and dialysis (renal hyperparathyroidism), parathyroid surgery remains an important treatment option in the spectrum of the disease. Patients with severe and complicated renal hyperparathyroidism (HPT), refractory or intolerant to medical therapy and patients with specific requirements in prospect of or excluded from renal transplantation may require parathyroidectomy for renal hyperparathyroidism.

Methods

Present standard and actual controversial issues regarding surgical treatment of patients with hyperparathyroidism due to chronic renal failure were identified, and pertinent literature was searched and reviewed. Whenever applicable, evaluation of the level of evidence concerning diagnosis and management of renal hyperparathyroidism according to standard criteria and recommendation grading were employed. Results were discussed at the 6th Workshop of the European Society of Endocrine Surgeons entitled Hyperparathyroidism due to multiple gland disease: An evidence-based perspective.

Results

Presently, literature reveals scant data, especially, no prospective randomized studies to provide sufficient levels of evidence to substantiate recommendations for surgery in renal hyperparathyroidism. Appropriate surgical management of renal hyperparathyroidism involves standard bilateral exploration with bilateral cervical thymectomy and a spectrum of four standardized types of parathyroid resection that reveal comparable outcome results with regard to levels of evidence and recommendation. Specific patient requirements may favour one over the other procedure according to individualized demands.

Conclusions

Surgery for patients with renal hyperparathyroidism in the era of calcimimetics continues to play an important role in selected patients and achieves efficient control of hyperparathyroidism. The overall success rate and long-term control of renal hyperparathyroidism and optimal handling of postoperative metabolic effects also depend on the timely indication, individually suitable type of parathyroid resection and specialized endocrine surgery.

Tentori F, Wang M, Bieber BA, Karaboyas A, Li Y, Jacobson SH et al (2015) Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: The DOPPS Study. Clin J Am Soc Nephrol 10(1):98–109PubMedCentralPubMedCrossRef

Ishani A, Liu J, Wetmore JB, Lowe KA, Do T, Bradbury BD et al (2015) Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis. Clin J Am Soc Nephrol 10(1):90–97PubMedCentralPubMedCrossRef

Sackett DL. Evidence-based medicine. Wiley; 2000.

Heinrich S, Schäfer M, Rousson V, Clavien P-A (2006) Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg 243(2):154PubMedCentralPubMedCrossRef

Pitt SC, Sippel RS, Chen H (2009) Secondary and tertiary hyperparathyroidism, state of the art surgical management. Surg Clin North Am 89(5):1227–1239PubMedCentralPubMedCrossRef

Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 113:S1

Kidney Foundation (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kid Dis 42(S1)

Tominaga Y, Matsuoka S, Sato T (2005) Surgical indications and procedures of parathyroidectomy in patients with chronic kidney disease. Ther Apher Dial 9(1):44–47PubMedCrossRef

Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15(8):2208–2218PubMedCrossRef

10.

Eknoyan G, Levin NW (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1–S266

11.

Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International Supplements 3(1):1–150CrossRef

12.

Young EW, Albert JM, Satayathum S, Goodkin DA, Pisoni RL, Akiba T et al (2005) Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 67(3):1179–1187PubMedCrossRef

13.

Matsuoka S, Tominaga Y, Sato T, Uno N, Hiramitu T, Goto N et al (2008) Relationship between the dimension of parathyroid glands estimated by ultrasonography and the hyperplastic pattern in patients with renal hyperparathyroidism. Ther Apher Dial 12(5):391–395PubMedCrossRef

14.

Chroustova D, Kubinyi J, Trnka J, Adamek S (2014) The role of 99mTc-MIBI SPECT/low dose CT with 3D subtraction in patients with secondary hyperparathyroidism due to chronic kidney disease. Endocr Regul 48(2):55–63PubMedCrossRef

15.

Michaud L, Burgess A, Huchet V, Lefevre M, Tassart M, Ohnona J et al (2014) Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism? J Clin Endocrinol Metab 99(12):4531–4536PubMedCrossRef

16.

Alkhalili E, Tasci Y, Aksoy E, Aliyev S, Soundararajan S, Taskin E et al (2015) The utility of neck ultrasound and sestamibi scans in patients with secondary and tertiary hyperparathyroidism. World J Surg 39(3):701–705PubMedCrossRef

17.

Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG et al (2004) Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350(15):1516–1525PubMedCrossRef

18.

Vervloet M, du Buf-Vereijken P, van Loon BP, Manamley N, Reichert L, Gregoor PS (2013) Cinacalcet for secondary hyperparathyroidism: from improved mineral levels to improved mortality? Neth J Med 71(7):348–354PubMed

19.

Moe SM, Cunningham J, Bommer J, Adler S, Rosansky SJ, Urena-Torres P et al (2005) Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl. Nephrol Dial Transplant 20(10):2186–2193PubMedCrossRef

20.

Raggi P, Chertow GM, Torres PU, Csiky B, Naso A, Nossuli K et al (2011) The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant 26(4):1327–1339PubMedCrossRef

21.

Ketteler M, Martin KJ, Wolf M, Amdahl M, Cozzolino M, Goldsmith D et al (2012) Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study. Nephrol Dial Transplant 27(8):3270–3278PubMedCentralPubMedCrossRef

22.

Goldsmith D, Covic A, Vervloet M, Cozzolino M, Nistor I, Chronic Kidney Disease-Mineral Bone Disease Working Group et al (2015) Should patients with CKD stage 5D and biochemical evidence of secondary hyperparathyroidism be prescribed calcimimetic therapy? An ERA-EDTA position statement. Nephrol Dial Transplant 30(5):698–700PubMedCrossRef

23.

Moe SM, Chertow GM, Coburn JW, Quarles LD, Goodman WG, Block GA et al (2005) Achieving NKF-K/DOQI™ bone metabolism and disease treatment goals with cinacalcet HCl. Kidney Int 67(2):760–771PubMedCrossRef

24.

Prieto FT, Blanco GB, Garcia MN, Chaves VC, GarcíaJiménez R, Palomo PP et al (2009) Calcimimetics and bone mineral density in renal transplant patients with persistent secondary hyperparathyroidism. Transplant Proc 41(6):2144–2147CrossRef

25.

Weber KJ, Misra S, Lee JK, Wilhelm SW, DeCresce R, Prinz RA (2004) Intraoperative PTH monitoring in parathyroid hyperplasia requires stricter criteria for success. Surgery 136(6):1154–1159PubMedCrossRef

26.

Tominaga Y, Matsuoka S, Uno N, Sato T (2008) Parathyroidectomy for secondary hyperparathyroidism in the era of calcimimetics. Ther Apher Dial 12(s1):S21–S26PubMedCrossRef

27.

Kovacevic B, Ignjatovic M, Zivaljevic V, Cuk V, Scepanovic M, Petrovic Z et al (2012) Parathyroidectomy for the attainment of NKF-K/DOQI and KDIGO recommended values for bone and mineral metabolism in dialysis patients with uncontrollable secondary hyperparathyroidism. Langenbecks Arch Surg 397(3):413–420PubMedCrossRef

28.

Mazzaferro S, Pasquali M, Farcomeni A, Vestri AR, Filippini A, Romani AM et al (2008) Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients. Nephrol Dial Transplant 23(7):2319–2323PubMedCrossRef

29.

Stanbury S, Lumb G, Nicholson W (1960) Elective subtotal parathyroidectomy for renal hyperparathyroidism. Lancet 275(7128):793–798CrossRef

30.

Madorin C, Owen RP, Fraser WD, Pellitteri PK, Radbill B, Rinaldo A et al (2012) The surgical management of renal hyperparathyroidism. Eur Arch Otorhinolaryngol 269(6):1565–1576PubMedCrossRef

31.

Schneider R, Bartsch DK (2015) Role of surgery in the treatment of renal secondary hyperparathyroidism. Br J Surg 102(4):289–290PubMedCrossRef

32.

Gasparri G, Camandona M, Abbona GC, Papotti M, Jeantet A, Radice E et al (2001) Secondary and tertiary hyperparathyroidism: causes of recurrent disease after 446 parathyroidectomies. Ann Surg 233(1):65PubMedCentralPubMedCrossRef

33.

Tominaga Y, Katayama A, Sato T, Matsuoka S, Goto N, Haba T et al (2003) Re-operation is frequently required when parathyroid glands remain after initial parathyroidectomy for advanced secondary hyperparathyroidism in uraemic patients. Nephrol Dial Transplant 18(3):iii65–iii70PubMed

34.

Triponez F, Kebebew E, Dosseh D, Duh QY, Hazzan M, Noel C et al (2006) Less-than-subtotal parathyroidectomy increases the risk of persistent/recurrent hyperparathyroidism after parathyroidectomy in tertiary hyperparathyroidism after renal transplantation. Surgery 140(6):990–997, Discussion 7–9 PubMedCrossRef

35.

Wagner PK, Seesko HG, Rothmund M (1991) Replantation of cryopreserved human parathyroid tissue. World J Surg 15(6):751–755PubMedCrossRef

36.

Wells SA Jr, Ellis GJ, Gunnells JC, Schneider AB, Sherwood LM (1976) Parathyroid autotransplantation in primary parathyroid hyperplasia. N Engl J Med 295(2):57–62PubMedCrossRef

37.

Casanova D, Sarfati E, De Francisco A, Amado JA, Arias M, Dubost C (1991) Secondary hyperparathyroidism: diagnosis of site of recurrence. World J Surg 15(4):546–549, discussion 9–50 PubMedCrossRef

38.

Schlosser K, Sitter H, Rothmund M, Zielke A (2004) Assessing the site of recurrence in patients with secondary hyperparathyroidism by a simplified Casanova autograftectomy test. World J Surg 28(6):583–588PubMedCrossRef

39.

Rothmund M, Wagner PK, Schark C (1991) Subtotal parathyroidectomy versus total parathyroidectomy and autotransplantation in secondary hyperparathyroidism: a randomized trial. World J Surg 15(6):745–750PubMedCrossRef

40.

Richards ML, Wormuth J, Bingener J, Sirinek K (2006) Parathyroidectomy in secondary hyperparathyroidism: Is there an optimal operative management? Surgery 139(2):174–180PubMedCrossRef

41.

Lorenz K, Sekulla C, Dralle H (2013) Chirurgisches Management des renalen Hyperparathyreoidismus. Zentralbl Chir 138(Suppl 2):e47–e54PubMed

42.

Schneider R, Bartsch DK, Schlosser K (2013) Relevance of bilateral cervical thymectomy in patients with renal hyperparathyroidism: analysis of 161 patients undergoing reoperative parathyroidectomy. World J Surg 37(9):2155–2161PubMedCrossRef

43.

David DS, Sakai S, Brennan BL, Riggio RA, Cheigh J, Stenzel KH et al (1973) Hypercalcemia after renal transplantation. Long-term follow-up data. N Engl J Med 289(8):398–401PubMedCrossRef

44.

Geis WP, Popovtzer MM, Corman JL, Halgrimson CG, Groth CG, Starzi TE (1973) The diagnosis and treatment of hyperparathyroidism after renal homotransplantation. Surgery, Gynecology and Obstetrics 137(6):997–1010PubMedCentralPubMed

45.

Rostaing L, Moreau-Gaudry X, Baron E, Cisterne JM, Monrozies-Bernadet P, Durand D (1997) Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism. Clin Nephrol 47(4):248–255PubMed

46.

Lee PP, Schiffmann L, Offermann G, Beige J (2004) Effects of parathyroidectomy on renal allograft survival. Kidney Blood Press Res 27(3):191–196PubMedCrossRef

47.

Evenepoel P, Claes K, Kuypers DR, Debruyne F, Vanrenterghem Y (2007) Parathyroidectomy after successful kidney transplantation: a single centre study. Nephrol Dial Transplant 22(6):1730–1737PubMedCrossRef

48.

Evenepoel P, Claes K, Kuypers D, Maes B, Vanrenterghem Y (2005) Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study. Nephrol Dial Transplant 20(8):1714–1720PubMedCrossRef

49.

Massfelder T, Parekh N, Endlich K, Saussine C, Steinhausen M, Helwig JJ (1996) Effect of intrarenally infused parathyroid hormone-related protein on renal blood flow and glomerular filtration rate in the anaesthetized rat. Br J Pharmacol 118(8):1995–2000PubMedCentralPubMedCrossRef

50.

Ogata H, Ritz E, Odoni G, Amann K, Orth SR (2003) Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors. J Am Soc Nephrol 14(4):959–967PubMedCrossRef

51.

Kerby JD, Rue LW, Blair H, Hudson S, Sellers MT, Diethelm AG (1998) Operative treatment of tertiary hyperparathyroidism: a single-center experience. Ann Surg 227(6):878–886PubMedCentralPubMedCrossRef

52.

Schwarz A, Rustien G, Merkel S, Radermacher J, Haller H (2007) Decreased renal transplant function after parathyroidectomy. Nephrol Dial Transplant 22(2):584–591PubMedCrossRef

53.

Jeon HJ, Kim YJ, Kwon HY, Koo TY, Baek SH, Kim HJ et al (2012) Impact of parathyroidectomy on allograft outcomes in kidney transplantation. Transpl Int 25(12):1248–1256PubMedCrossRef

54.

Schlosser K, Endres N, Celik I, Fendrich V, Rothmund M, Fernandez ED (2007) Surgical treatment of tertiary hyperparathyroidism: the choice of procedure matters! World J Surg 31(10):1947–1953PubMedCrossRef

55.

Ogg CS (1967) Total parathyroidectomy in treatment of secondary (renal) hyperparathyroidism. Br Med J 4(5575):331–334PubMedCentralPubMedCrossRef

56.

Schlosser K, Veit JA, Witte S, Fernández ED, Victor N, Knaebel H-P et al (2007) Comparison of total parathyroidectomy without autotransplantation and without thymectomy versus total parathyroidectomy with autotransplantation and with thymectomy for secondary hyperparathyroidism: TOPAR PILOT-Trial. Trials 8(1):22PubMedCentralPubMedCrossRef

57.

Schneider R, Slater EP, Karakas E, Bartsch DK, Schlosser K (2012) Initial parathyroid surgery in 606 patients with renal hyperparathyroidism. World J Surg 36(2):318–326PubMedCrossRef

58.

Lorenz K, Ukkat J, Sekulla C, Gimm O, Brauckhoff M, Dralle H (2006) Total parathyroidectomy without autotransplantation for renal hyperparathyroidism: experience with a qPTH-controlled protocol. World J Surg 30(5):743–751PubMedCrossRef

59.

Pattou FN, Pellissier LC, Noël C, Wambergue F, Huglo DG, Proye CA (2000) Supernumerary parathyroid glands: frequency and surgical significance in treatment of renal hyperparathyroidism. World J Surg 24(11):1330–1334PubMedCrossRef

60.

Schneider R, Waldmann J, Ramaswamy A, Fernandez ED, Bartsch DK, Schlosser K (2011) Frequency of ectopic and supernumerary intrathymic parathyroid glands in patients with renal hyperparathyroidism: analysis of 461 patients undergoing initial parathyroidectomy with bilateral cervical thymectomy. World J Surg 35(6):1260–1265PubMedCrossRef

61.

Aly A, Douglas M (2003) Embryonic parathyroid rests occur commonly and have implications in the management of secondary hyperparathyroidism. ANZ J Surg 73(5):284–288PubMedCrossRef

62.

Maxwell PH, Winearls CG (1997) Recurrence of autonomous hyperparathyroidism in dialysis patients. Nephrol Dial Transplant 12(10):2195–2200PubMedCrossRef

63.

Gaz RD, Doubler PB, Wang C (1987) The management of 50 unusual hyperfunctioning parathyroid glands. Surgery 102(6):949–957PubMed

64.

Ockert S, Willeke F, Richter A, Jonescheit J, Schnuelle P, van der Woude F et al (2002) Total parathyroidectomy without autotransplantation as a standard procedure in the treatment of secondary hyperparathyroidism. Langenbecks Arch Surg 11387(5–6):204–209CrossRef

65.

Coulston JE, Egan R, Willis E, Morgan JD (2010) Total parathyroidectomy without autotransplantation for renal hyperparathyroidism. Br J Surg 97(11):1674–1679PubMedCrossRef

66.

Galloway PA, El-Damanawi R, Bardsley V, Pritchard NR, Fry AC, Ojha SK et al (2015) Vitamin K antagonists predispose to calciphylaxis in patients with end-stage renal disease. Nephron 129(3):197–201PubMedCrossRef

67.

Weenig RH, Sewell LD, Davis MDP, McCarthy JT, Pittelkow MR (2007) Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol 56(4):569–579PubMedCrossRef

68.

Girotto JA, Harmon JW, Ratner LE, Nicol TL, Wong L, Chen H (2001) Parathyroidectomy promotes wound healing and prolongs survival in patients with calciphylaxis from secondary hyperparathyroidism. Surgery 130(4):645–650, discussion 50–1 PubMedCrossRef

69.

Duh Q, Lim RC, Clark OH (1991) Calciphylaxis in secondary hyperparathyroidism: diagnosis and parathyroidectomy. Arch Surg 126(10):1213–1219PubMedCrossRef

70.

Kang AS, McCarthy JT, Rowland C, Farley DR, Van Heerden JA (2000) Is calciphylaxis best treated surgically or medically? Surgery 128(6):967–972PubMedCrossRef

71.

Caccitolo JA, Farley DR, van Heerden JA, Grant CS, Thompson GB, Sterioff S (1997) The current role of parathyroid cryopreservation and autotransplantation in parathyroid surgery: an institutional experience. Surgery 122(6):1062–1067PubMedCrossRef

72.

Saxe AW, Spiegel AM, Marx SJ, Brennan MF (1982) Deferred parathyroid autografts with cryopreserved tissue after reoperative parathyroid surgery. Arch Surg 117(5):538–543PubMedCrossRef

73.

Feldman AL, Sharaf RN, Skarulis MC, Bartlett DL, Libutti SK, Weinstein LS et al (1999) Results of heterotopic parathyroid autotransplantation: a 13-year experience. Surgery 126(6):1042–1048PubMedCrossRef

74.

Borot S, Lapierre V, Carnaille B, Goudet P, Penfornis A (2010) Results of cryopreserved parathyroid autografts: a retrospective multicenter study. Surgery 147(4):529–535PubMedCrossRef

75.

Tominaga Y (2006) Surgical treatment of secondary hyperparathyroidism due to chronic kidney disease. Ups J Med Sci 111(3):277–292PubMedCrossRef

76.

Cohen MS, Dilley WG, Wells SA, Moley JF, Doherty GM, Sicard GA et al (2005) Long-term functionality of cryopreserved parathyroid autografts: a 13-year prospective analysis. Surgery 138(6):1033–1041PubMedCrossRef

77.

Agarwal A, Waghray A, Gupta S, Sharma R, Milas M (2013) Cryopreservation of parathyroid tissue: an illustrated technique using the Cleveland clinic protocol. J Am Coll Surg 216(1):e1–e9PubMedCrossRef

78.

Guerrero MA, Evans DB, Lee JE, Bao R, Bereket A, Gantela S et al (2008) Viability of cryopreserved parathyroid tissue: when is continued storage versus disposal indicated? World J Surg 32(5):836–839PubMedCrossRef

79.

Yoo J, Young JEM (2012) Secondary hyperparathyroidism: surgical. In: Khan AA, Clark OH (eds) Handbook of parathyroid diseases, 1st edn. Springer, New York, pp 159–180CrossRef

80.

Lokey J, Pattou F, Mondragon-Sanchez A, Minuto M, Mullineris B, Wambergue F et al (2000) Intraoperative decay profile of intact (1–84) parathyroid hormone in surgery for renal hyperparathyroidism—a consecutive series of 80 patients. Surgery 128(6):1029–1034PubMedCrossRef

81.

Barczyński M, Cichoń S, Konturek A, Cichoń W (2005) A randomised study on a new cost-effective algorithm of quick intraoperative intact parathyroid hormone assay in secondary hyperparathyroidism. Langenbecks Arch Surg 390(2):121–127PubMedCrossRef

82.

Seehofer D, Rayes N, Klupp J, Steinmüller T, Ulrich F, Müller C et al (2005) Predictive value of intact parathyroid hormone measurement during surgery for renal hyperparathyroidism. Langenbecks Arch Surg 390(3):222–229PubMedCrossRef

83.

Weber T, Zeier M, Hinz U, Schilling T, Büchler MW (2005) Impact of intraoperative parathyroid hormone levels on surgical results in patients with renal hyperparathyroidism. World J Surg 29(9):1176–1179PubMedCrossRef

84.

Pitt SC, Panneerselvan R, Chen H, Sippel RS (2010) Secondary and tertiary hyperparathyroidism: the utility of ioPTH monitoring. World J Surg 34(6):1343–1349PubMedCentralPubMedCrossRef

85.

Roshan A, Kamath B, Roberts S, Atkin S, England R (2006) Intra-operative parathyroid hormone monitoring in secondary hyperparathyroidism: is it useful? Clin Otolaryngol 31(3):198–203PubMedCrossRef

86.

Moor JW, Roberts S, Atkin SL, England RJ (2011) Intraoperative parathyroid hormone monitoring to determine long-term success of total parathyroidectomy for secondary hyperparathyroidism. Head Neck 33(3):293–296PubMed

87.

Muller-Stich BP, Brandle M, Binet I, Warschkow R, Lange J, Clerici T (2007) To autotransplant simultaneously or not–can intraoperative parathyroid hormone monitoring reliably predict early postoperative parathyroid hormone levels after total parathyroidectomy for hyperplasia? Surgery 142(1):47–56PubMedCrossRef

88.

Freriks K, Hermus AR, de Sévaux RG, Bonenkamp HJ, Biert J, den Heijer M et al (2010) Usefulness of intraoperative parathyroid hormone measurements in patients with renal hyperparathyroidism. Head Neck 32(10):1328–1335PubMedCrossRef

89.

Yamashita H, Cantor T, Uchino S, Watanabe S, Ogawa T, Moriyama T et al (2005) Sequential changes in plasma intact and whole parathyroid hormone levels during parathyroidectomy for secondary hyperparathyroidism. World J Surg 29(2):169–173PubMedCrossRef

90.

Bieglmayer C, Kaczirek K, Prager G, Niederle B (2006) Parathyroid hormone monitoring during total parathyroidectomy for renal hyperparathyroidism: pilot study of the impact of renal function and assay specificity. Clin Chem 52(6):1112–1119PubMedCrossRef

91.

Tominaga Y, Uchida K, Haba T, Katayama A, Sato T, Hibi Y et al (2001) More than 1,000 cases of total parathyroidectomy with forearm autograft for renal hyperparathyroidism. Am J Kidney Dis 38(4):S168–S171PubMedCrossRef

92.

Kestenbaum B, Andress DL, Schwartz SM, Gillen DL, Seliger SL, Jadav PR et al (2004) Survival following parathyroidectomy among United States dialysis patients. Kidney Int 66(5):2010–2016PubMedCrossRef

93.

Conzo G, Perna AF, Savica V, Palazzo A, Pietra CD, Ingrosso D et al (2013) Impact of parathyroidectomy on cardiovascular outcomes and survival in chronic hemodialysis patients with secondary hyperparathyroidism. A retrospective study of 50 cases prior to the calcimimetics era. BMC Surg 13(Suppl 2):S4PubMedCentralPubMedCrossRef

94.

Costa-Hong V, Jorgetti V, Gowdak LHW, Moyses RMA, Krieger EM, De Lima JJG (2007) Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism. Surgery 142(5):699–703PubMedCrossRef

95.

Cheng SP, Liu CL, Chen HH, Lee JJ, Liu TP, Yang TL (2009) Prolonged hospital stay after parathyroidectomy for secondary hyperparathyroidism. World J Surg 33(1):72–79PubMedCrossRef

96.

Ureña P, Kubrusly M, Mannstadt M, Sarfati E, Drueke T (1994) Total or subtotal parathyroidectomy in uremic patients? Clin Nephrol 41(1):59–60PubMed

97.

Sitges-Serra A, Caralps-Riera A (1987) Hyperparathyroidism associated with renal disease. Pathogenesis, natural history, and surgical treatment. Surg Clin North Am 67(2):359–377PubMed

98.

Florescu MC, Islam KM, Plumb TJ, Smith-Shull S, Nieman J, Mandalapu P (2014) Calcium supplementation after parathyroidectomy in dialysis and renal transplant patients. Int J Nephrol Renovasc Dis 7:183–190PubMedCentralPubMedCrossRef

99.

Latus J, Roesel M, Fritz P, Braun N, Ulmer C, Steurer W et al (2013) Incidence of and risk factors for hungry bone syndrome in 84 patients with secondary hyperparathyroidism. Int J Nephrol Renovasc Dis 6:131–137PubMedCentralPubMedCrossRef

100.

Torer N, Torun D, Micozkadioglu H, Noyan T, Ozdemir FN, Haberal M (2009) Predictors of early postoperative hypocalcemia in hemodialysis patients with secondary hyperparathyroidism. In: Transplantation Proceedings. Elsevier, Amsterdam

101.

Niramitmahapanya S, Sunthornthepvarakul T, Deerochanawong C, Sarinnapakorn V, Athipan P (2011) Role of loading calcitriol to control hypocalcemia after parathyroidectomy in chronic kidney disease. J Med Assoc Thai 94(3):295PubMed

102.

Goh BL, Yudisthra MG, Hisham AN (2010) Alkaline phosphatase predicts calcium requirements after total parathyroidectomy in patients receiving dialysis. Br J Surg 97(2):185–188PubMedCrossRef

103.

Kievit A, Tinnemans J, Idu M, Groothoff J, Surachno S, Aronson D (2010) Outcome of total parathyroidectomy and autotransplantation as treatment of secondary and tertiary hyperparathyroidism in children and adults. World J Surg 34(5):993–1000PubMedCentralPubMedCrossRef

104.

Mozes MF, Soper WD, Jonasson O, Lang GR (1980) Total parathyroidectomy and autotransplantation in secondary hyperparathyroidism. Arch Surg 115(4):378–385PubMedCrossRef

105.

Triponez F, Evenepoel P (2012) Pathophysiology and treatment of secondary and tertiary hyperparathyroidism. In: Oertli D, Udelsman R (eds) Surgery of the thyroid and parathyroid glands. Springer, Berlin Heidelberg, pp 517–536CrossRef

106.

Dewberry LC, Tata S, Graves S, Weber CJ, Sharma J (2014) Predictors of tertiary hyperparathyroidism: Who will benefit from parathyroidectomy? Surgery 156(6):1631–1637PubMedCrossRef

107.

Messa P, Cafforio C, Alfieri C (2011) Clinical impact of hypercalcemia in kidney transplant. International Journal of Nephrology 2011:906832PubMedCentralPubMedCrossRef

108.

Jamal SA, Miller PD (2013) Secondary and tertiary hyperparathyroidism. J Clin Densitom 16(1):64–68PubMedCrossRef

109.

Evenepoel P, Claes K, Kuypers D, Maes B, Bammens B, Vanrenterghem Y (2004) Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Nephrol Dial Transplant 19(5):1281–1287PubMedCrossRef

110.

Kuo LE, Wachtel H, Karakousis G, Fraker D, Kelz R (2014) Parathyroidectomy in dialysis patients. J Surg Res 190(2):554–558PubMedCrossRef

111.

Gupta PK, Smith RB, Gupta H, Forse RA, Fang X, Lydiatt WM (2012) Outcomes after thyroidectomy and parathyroidectomy. Head Neck 34(4):477–484PubMedCrossRef

112.

Torregrosa JV, Barros X (2013) Management of hypercalcemia after renal transplantation. Nefrologia 33(6):751–757PubMed

113.

Yamada S, Tokumoto M, Taniguchi M, Toyonaga J, Suehiro T, Eriguchi R, et al. (2015) Two years of cinacalcet hydrochloride treatment decreased parathyroid gland volume and serum parathyroid hormone level in hemodialysis patients with advanced secondary hyperparathyroidism. Therapeutic Apheresis and Dialysis

114.

Somnay YR, Weinlander E, Schneider DF, Sippel RS, Chen H (2014) The effect of cinacalcet on intraoperative findings in tertiary hyperparathyroidism patients undergoing parathyroidectomy. Surgery 156(6):1308–1314PubMedCentralPubMedCrossRef

115.

Evenepoel P, Van Den Bergh B, Naesens M, De Jonge H, Bammens B, Claes K et al (2009) Calcium metabolism in the early posttransplantation period. Clin J Am Soc Nephrol 4(3):665–672PubMedCentralPubMedCrossRef

116.

Triponez F, Clark OH, Vanrenthergem Y, Evenepoel P (2008) Surgical treatment of persistent hyperparathyroidism after renal transplantation. Ann Surg 248(1):18–30PubMedCrossRef

117.

Tominaga Y, Numano M, Tanaka Y, Uchida K, Takagi H, editors. Surgical treatment of renal hyperparathyroidism. Seminars in Surgical Oncology; 1997: Wiley.

118.

Tominaga Y, Tanaka Y, Sato K, Nagasaka T, Takagi H (1997) Histopathology, pathophysiology, and indications for surgical treatment of renal hyperparathyroidism. Semin Surg Oncol 13(2):78–86PubMedCrossRef

119.

Fukagawa M, Kitaoka M, Yi H, Fukuda N, Matsumoto T, Ogata E et al (1994) Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients. Nephron 68(2):221–228PubMedCrossRef

120.

Bonarek H, Merville P, Bonarek M, Moreau K, Morel D, Aparicio M et al (1999) Reduced parathyroid functional mass after successful kidney transplantation. Kidney Int 56(2):642–649PubMedCrossRef

121.

Muirhead N, Zaltman J, Gill J, Churchill D, Poulin-Costello M, Mann V et al (2014) Hypercalcemia in renal transplant patients: prevalence and management in Canadian transplant practice. Clin Transplant 28(2):161–165PubMedCrossRef

122.

Reinhardt W, Bartelworth H, Jockenhövel F, Schmidt-Gayk H, Witzke O, Wagner K et al (1998) Sequential changes of biochemical bone parameters after kidney transplantation. Nephrol Dial Transplant 13(2):436–442PubMedCrossRef

123.

Heaf J, Tvedegaard E, Kanstrup IL, Fogh-Andersen N (2000) Bone loss after renal transplantation: role of hyperparathyroidism, acidosis, cyclosporine and systemic disease. Clin Transplant 14(5):457–463PubMedCrossRef

124.

Ozdemir F, Afsar B, Akgul A, Usluoğulları C, Akçay A, Haberal M (2006) Persistent hypercalcemia is a significant risk factor for graft dysfunction in renal transplantation recipients. Transplant Proc 38(2):480–482PubMedCrossRef

125.

Messa P, Sindici C, Cannella G, Miotti V, Risaliti A, Gropuzzo M et al (1998) Persistent secondary hyperparathyroidism after renal transplantation. Kidney Int 54(5):1704–1713PubMedCrossRef

126.

Torres A, Lorenzo V, Salido E (2002) Calcium metabolism and skeletal problems after transplantation. J Am Soc Nephrol 13(2):551–558PubMed

127.

Shen WT, Kebebew E, Suh I, Duh QY, Clark OH (2009) Two hundred and two consecutive operations for secondary hyperparathyroidism: has medical management changed the profiles of patients requiring parathyroidectomy? Surgery 146(2):296–299PubMedCrossRef

128.

Ferreira GF, Montenegro FLM, Machado DJ, Ianhez LE, Nahas WC, David-Neto E (2011) Parathyroidectomy after kidney transplantation: short-and long-term impact on renal function. Clinics (Sao Paulo) 66(3):431–435CrossRef

129.

Park JH, Kang S-W, Jeong JJ, Nam K-H, Chang HS, Chung WY et al (2011) Surgical treatment of tertiary hyperparathyroidism after renal transplantation: a 31-year experience in a single institution. Endocr J 58(10):827–833PubMedCrossRef

130.

Parikh S, Nagaraja H, Agarwal A, Samavedi S, Visger J, Nori U et al (2013) Impact of post-kidney transplant parathyroidectomy on allograft function. Clin Transplant 27(3):397–402PubMedCentralPubMedCrossRef

131.

Pinheiro HS, Câmara NOS, Osaki KS, De Moura LAR, Pacheco-Silva A (2005) Early presence of calcium oxalate deposition in kidney graft biopsies is associated with poor long-term graft survival. Am J Transplant 5(2):323–329PubMedCrossRef

132.

Meola M, Petrucci I, Barsotti G (2009) Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism. Nephrol Dial Transplant 24(3):982–989PubMedCentralPubMedCrossRef

133.

Komaba H, Nakanishi S, Fujimori A, Tanaka M, Shin J, Shibuya K et al (2010) Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism. Clin J Am Soc Nephrol 5(12):2305–2314PubMedCentralPubMedCrossRef

134.

Yuan CM, Nee R, Narayan R, Abbott KC (2012) Treatment of secondary hyperparathyroidism with parathyroidectomy instead of cinacalcet: time to pick the low-hanging fruit? Am J Kidney Dis 60(2):179–181PubMedCrossRef

135.

Kandil E, Florman S, Alabbas H, Abdullah O, McGee J, Noureldine S et al (2010) Exploring the effect of parathyroidectomy for tertiary hyperparathyroidism after kidney transplantation. Am J Med Sci 339(5):420–424PubMedCentralPubMedCrossRef

136.

Copley JB, Wüthrich RP (2011) Therapeutic management of post-kidney transplant hyperparathyroidism. Clin Transplant 25(1):24–39PubMedCrossRef

137.

Rayes N, Seehofer D, Schindler R et al (2008) Long-term results of subtotal vs total parathyroidectomy without autotransplantation in kidney transplant recipients. Arch Surg 143(8):756–761

138.

Sadideen HM, Taylor JD, Goldsmith DJ (2012) Total parathyroidectomy without autotransplantation after renal transplantation for tertiary hyperparathyroidism: long-term follow-up. Int Urol Nephrol 44(1):275–281

139.

Drakopoulos S, Koukoulaki M, Apostolou T et al (2009) Total parathyroidectomy without autotransplantation in dialysis patients and renal transplant recipients, long-term follow-up evaluation. Am J Surg 198(2):178–183

140.

Tseng PY, Yang WC, Yang CY et al (2015) Long-term Outcomes of Parathyroidectomy in Kidney Transplant Recipients with Persistent Hyperparathyroidism. Kidney Blood Press Res 40(4):386–394

141.

Pitt SC, Panneerselvan R, Chen H et al (2009) Tertiary hyperparathyroidism: is less than a subtotal resection ever appropriate? A study of long-term outcomes. Surgery 146(6):1130–1137

Title: Surgical management of secondary hyperparathyroidism in chronic kidney disease—a consensus report of the European Society of Endocrine Surgeons
Authors: Kerstin Lorenz
Detlef K. Bartsch
Juan J. Sancho
Sebastien Guigard
Frederic Triponez
Publication date: 01-12-2015
Publisher: Springer Berlin Heidelberg
Published in: Langenbeck's Archives of Surgery / Issue 8/2015
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI: https://doi.org/10.1007/s00423-015-1344-5

At a glance: The STEP trials

Springer Medicine

Surgical management of secondary hyperparathyroidism in chronic kidney disease—a consensus report of the European Society of Endocrine Surgeons

Abstract

Background

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 8/2015

Effect of perioperative dexamethasone on subjective voice quality after thyroidectomy: a meta-analysis and systematic review

Totally laparoscopic gastrectomy for gastric cancer after endoscopic submucosal dissection: a propensity score matching analysis

Automated low flow pump system for the treatment of refractory ascites: a single-center experience

Completion pancreatectomy for recurrent pancreatic cancer in the remnant pancreas: report of six cases and a review of the literature

Multigland primary hyperparathyroidism—frequently considered, seldom encountered

Sporadic multiple parathyroid gland disease—a consensus report of the European Society of Endocrine Surgeons (ESES)